Adam W, Grimm GN, Saha-Mller CR
Physical capacity, like the ability to climb stairs, walk distances, or complete workouts that were previously impossible
Drug class: GIP/GLP-1/Glucagon receptor triagonist Route: Once-weekly subcutaneous injection Developer: Eli Lilly and Company Phase: Phase 3 (TRIUMPH program) Status: Investigational NOT TEY approved by FDA or EMA (despite what your online dealer told you ) Here's how it compares to the drugs most people already know: - Semaglutide (Ozempic/Wegovy): activates 1 receptor GLP-1 - Tirzepatide (Mounjaro/Zepbound): activates 2 receptors GLP-1 + GIP - Retatrutide: activates 3 receptors GLP-1 + GIP + Glucagon That third receptor the glucagon receptor is the differentiator
L-Citrulline accelerates ammonia clearance, decreases muscle pH that occurs during severe exertion
Phase 2 Improved GLP-1 Longevity Berberine HCl and African mango take it a step further helping extend the lifespan of your natural GLP-1 hormone by supporting the inhibition of the enzymes that break it down, so the GLP-1 you produce keeps working longer
Some patients benefit from switching to gentler laundry detergents and avoiding fabric softeners that may irritate sensitive skin
)
